Family Medicine Doctors in North Vernon, IN Accepting Medicare

10 Family Medicine doctors found. Showing 1 - 10

Sesame Dijeng, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 301 Henry St, North Vernon, IN 47265 Phone: 812-352-4454

Jennifer Lynn Stanley, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 301 Henry St, North Vernon, IN 47265 Phone: 812-352-4300

John Benet Schuck, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 301 Henry St, North Vernon, IN 47265 Phone: 812-352-4300

Gregory Austin Politzer, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 301 Henry St, North Vernon, IN 47265 Phone: 812-352-4300    Fax: 812-352-4301

Vasundhara Voleti, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 301 Henry St, North Vernon, IN 47265 Phone: 812-352-4200    Fax: 812-352-4201

Dr. Stephanie M Johnson, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 301 Henry St, North Vernon, IN 47265 Phone: 812-352-4454    Fax: 812-418-4230

Dr. Luis S Bengero, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 301 Henry St, North Vernon, IN 47265 Phone: 812-352-4300

Dr. Neil Strait Hill, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 939 Veterans Dr, Suite A, North Vernon, IN 47265 Phone: 812-352-8333    Fax: 812-352-8233

Dr. Anton Grankin, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 301 Henry St, North Vernon, IN 47265 Phone: 812-352-4300

Jefferson Qualls, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 301 Henry St, North Vernon, IN 47265 Phone: 317-695-1241

News Archive

AGTC receives grant to evaluate Phase II Human Clinical Trial for LCA retinal disease

Applied Genetic Technologies Corporation, a privately-held, clinical stage biotechnology company developing novel systems to deliver human therapeutics, announces that it has received a grant of $1 million from the Food and Drug Administration (FDA Orphan Drugs Program). The grant will fund a Phase II Human Clinical Trial evaluating the safety and efficacy of a treatment for Leber congenital amaurosis (LCA), a genetic retinal disease known to cause blindness at an early age.

Edwards Lifesciences announces FDA approval of SAPIEN 3 transcatheter aortic heart valve

Edwards Lifesciences Corporation, the global leader in the science of heart valves and hemodynamic monitoring, today announced U.S. Food and Drug Administration approval of its most advanced transcatheter aortic heart valve – the Edwards SAPIEN 3 valve with the Commander Delivery System – for the treatment of high-risk patients suffering from severe, symptomatic aortic stenosis.

DBS achieves stable motor improvements in Parkinson's

Deep brain stimulation for patients with Parkinson's disease achieves improvements in motor symptoms that are sustained over 3 years, report researchers.

A parent-to-parent campaign to get vaccine rates up

In 2017, Kim Nelson had just moved her family back to her hometown in South Carolina. Boxes were still scattered around the apartment, and while her two young daughters played, Nelson scrolled through a newspaper article on her phone.

Critical lock and key mechanism found for the assembly of tumor blood vessels

A critical lock and key mechanism that allows the final step in the completion of new blood vessel formation has been identified by a University of California, San Diego (UCSD) School of Medicine team in research that promises to lead to a new way to halt tumor growth by cutting off the tumor blood supply.

Read more Medical News

› Verified 8 days ago